Vanguard Capital Management
DCOY

Vanguard Capital Management’s Decoy Therapeutics DCOY Stock Holding History

Vanguard Capital Management’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Buy
+4,034
New +$24.8K ﹤0.01% 3984

Other funds holding DCOY

TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Vanguard Capital Management's DCOY Position: Q2 2026 in Review

Vanguard Capital Management opened a new position in Decoy Therapeutics (DCOY) in Q2 2026: 4,034 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #3984 among its holdings.

4 funds tracked by Wall St. Rank hold DCOY as of Q2 2026.

  • Vanguard Capital Management held 4,034 shares of Decoy Therapeutics worth $29K as of Q2 2026.
  • Decoy Therapeutics was a new Vanguard Capital Management position in Q2 2026.
  • Decoy Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3984 holding.
  • 4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.